EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IGFBP-3 enhances irinotecan efficacy in colorectal cancer via ROS-mediated apoptosis and β-catenin suppression

Elahe Gharehkhani, Mohammad Karami, Abouzar Bagheri, Mahboube Rahmati Kukandeh, Mohammad Shokrzadeh

Research in Pharmaceutical Sciences · 2026-07 · 21 (4) · 521-535

DOI: 10.4103/rps.rps_153_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research in Pharmaceutical Sciences, online erschienen am 27.07.2026. Verfasst von Elahe Gharehkhani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose: Colorectal cancer, a leading cause of mortality, is treated with surgery early and irinotecan (IRI) chemotherapy in advanced stages. Insulin-like growth factor-binding protein 3 (IGFBP-3), regulated by p53, mediates tumor suppression and apoptosis. This study evaluates the combined therapeutic effects of IGFBP-3 and IRI in colorectal cancer. Experimental approach: SW480 colorectal cancer cells were treated with IGFBP-3, IRI, and their combination; IC 50 values were determined by MTT assay, and combination effects were analyzed by CompuSyn. Oxidative stress markers, apoptosis, and cell cycle progression were assessed utilizing flow cytometry. Furthermore, caspase 3/7 activity was measured, and expression levels of Bax, Bcl2 , and β-catenin were determined using RT-PCR. Findings/Results: The MTT assay revealed IC 50 of 8.4 μM for IRI and 43.03 nM for IGFBP-3, with CompuSyn confirming synergistic interaction (CI < 1). Compared to single agents, the combination treatment significantly enhanced apoptosis, induced greater G 2 /M cell cycle arrest, and markedly increased levels of ROS, MDA, and protein carbonyls while significantly depleting GSH. At the molecular level, the combination synergistically upregulated pro-apoptotic Bax and downregulated anti-apoptotic Bcl2 and oncogenic β-catenin . Conclusion and implications: Our results indicated that IRI and IGFBP-3 show cytotoxicity, with IGFBP-3 enhancing IRI effect by inhibiting Wnt/β-catenin and increasing drug uptake, warranting assessment in normal cells.

Schlagwörter

Stichwörter der Autor:innen

Colorectal neoplasmCombination therapyInsulin-like growth factor-binding protein 3 (IGFBP-3)IrinotecanOxidative stressWnt pathway

Autor:innen und Institutionen

  • Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
  • Medical Plants Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
  • Immunogenetics Research Center, Department of Clinical Biochemistry and Medical Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Zitieren

APA

Gharehkhani, E., Karami, M., Bagheri, A., Kukandeh, M. R., & Shokrzadeh, M. (2026). IGFBP-3 enhances irinotecan efficacy in colorectal cancer via ROS-mediated apoptosis and β-catenin suppression. Research in Pharmaceutical Sciences, 21(4), 521-535. https://doi.org/10.4103/rps.rps_153_25

Vancouver

Gharehkhani E, Karami M, Bagheri A, Kukandeh MR, Shokrzadeh M. IGFBP-3 enhances irinotecan efficacy in colorectal cancer via ROS-mediated apoptosis and β-catenin suppression. Research in Pharmaceutical Sciences. 2026;21(4):521-535. doi:10.4103/rps.rps_153_25

BibTeX
@article{Gharehkhani2026,
  author = {Gharehkhani, Elahe and Karami, Mohammad and Bagheri, Abouzar and Kukandeh, Mahboube Rahmati and Shokrzadeh, Mohammad},
  title = {IGFBP-3 enhances irinotecan efficacy in colorectal cancer via ROS-mediated apoptosis and β-catenin suppression},
  journal = {Research in Pharmaceutical Sciences},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {521--535},
  doi = {10.4103/rps.rps_153_25}
}
Kostenlos starten →